U.S Futures rising – Watch REGN, TSLA, NFLX

,

The S&P 500 Futures are rebounding after they closed in the red on Friday

Trading floor 2

The S&P 500 Futures are rebounding after they closed in the red on Friday.

Later today, the Federal Reserve Bank of Chicago will post October National Activity Index (0.27 expected). Research firm Markit will publish preliminary readings of November Manufacturing PMI (52.5 expected) and November Services PMI (55.8 expected).

European indices are on the upside. AstraZeneca announced that its candidate vaccine developed with Oxford University is 70% effective on average. Research firm Markit has published preliminary readings of November Manufacturing PMI for the eurozone at 53.6 (vs 54.2 expected), for Germany at 57.9 (vs 57.3 expected), for France at 49.1 (vs 49.9 expected) and for the U.K. at 55.2 (vs 51.6 expected). Also, the preliminary readings of November Services PMI for the eurozone was published at 41.3 (vs 44.1 expected), at 46.2 for Germany (vs 47.5 expected), at 38.0 for France (vs 39.0 expected) and at 45.8 for the U.K. (vs 46.0 expected).

Asian indices closed slightly on the upside except the Hong Kong HSI. The Japanese Nikkei was closed for holiday.

WTI Crude Oil remains strong. The total number of rotary rigs in the U.S. slipped to 310 as of November 20 from 312 in the prior week, while rigs in Canada rose to 101 from 89, according to Baker Hughes.

U.S indices closed down on Friday, pressured by Banks (-1.15%), Consumer Services (-1.14%) and Software & Services (-1.13%) sectors.

Approximately 90% of stocks in the S&P 500 Index were trading above their 200-day moving average and 81% were trading above their 20-day moving average. The VIX Index rose 0.59pt (+2.55%) to 23.7 and WTI Crude Oil jumped $0.5 (+1.19%) to $42.4 at the close.

Gold and U.S dollar consolidate as investors favor riskier assets currently.

Gold fell 3.86 dollars (-0.21%) to 1867.13 dollars.

The dollar index declined 0.34pt to 92.056.


U.S. Equity Snapshot


Regeneron Pharmaceuticals (REGN), a biotechnology company, reported that its REGEN-COV2, an antibody cocktail for Covid-19, has received Emergency Use Authorization from the U.S. Food and Drug Administration. The company said it "now expects to have REGEN-COV2 treatment doses ready for approximately 80,000 patients by the end of November, approximately 200,000 patients by the first week of January, and approximately 300,000 patients in total by the end of January 2021".


Source: TradingView, GAIN Capital

Tesla (TSLA)'s, the electric-vehicle maker, price target was raised to 560 dollars from 500 dollars at Wedbush.

Netflix (NFLX)'s, the video streaming service, target price was raised to 628 dollars from 615 dollars at JPMorgan.

More from Equities

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.